Back
Intellia Therapeutics Quote, Financials, Valuation and Earnings
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
29
NTLA
Intellia Therapeutics
Last Price:
22.53
Seasonality Move:
-1.88%
7 Day Trial
ALL ACCESS PASS
$
7
Former Chicago Pit Trader Exposes Shocking Trading Advantage:
See How to Target Up to 383% OVERNIGHTIntellia Therapeutics Price Quote
$22.53
-0.02 (-0.09%)
(Updated: September 18, 2024 at 6:55 PM ET)
Intellia Therapeutics Key Stats
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Day range:
$21.77 - $23.15
52-week range:
$19.21 - $34.94
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
45.88
P/B ratio:
2.36%
Volume:
1.5M
Avg. volume:
1.2M
1-year change:
-37.05%
Market cap:
$2.3B
Revenue:
$36.3M
EPS:
$-5.48
How Much Does Intellia Therapeutics Make?
-
How Much Are Intellia Therapeutics's Sales Annually?
NTLA Revenues are $36.3M -
How Much Profit Does Intellia Therapeutics's Make A Year?
NTLA net income is -$481.2M
Is Intellia Therapeutics Growing As A Company?
-
What Is Intellia Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.49% -
What Is Intellia Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Intellia Therapeutics Stock Price Performance
-
Did Intellia Therapeutics Stock Go Up Last Month?
Intellia Therapeutics share price went down by -0.35% last month -
Did NTLA's Share Price Rise Over The Last Year?
NTLA share price fell by -37.05% over the past 1 year
What Is Intellia Therapeutics 52-Week High & Low?
-
What Is Intellia Therapeutics’s 52-Week High Share Price?
Intellia Therapeutics has traded as high as $34.94 over the past 52 weeks -
What Is Intellia Therapeutics’s 52-Week Low Share Price?
Intellia Therapeutics has traded as low as $19.21 over the past 52 weeks
Intellia Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Intellia Therapeutics?
-
How Much Debt Does Intellia Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Intellia Therapeutics Have?
Cash and short term investments quarterly total is $691.1M -
What Is Intellia Therapeutics’s Book Value Per Share?
Book value per share is 9.88
Is Intellia Therapeutics Cash Flow Positive?
-
What Is NTLA Cash Flow From Operations?
Cash flow from operations (TTM) is -$373.3M -
What Is Intellia Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $226.8M -
What Is Intellia Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $107.2M
Intellia Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
NTLA return on invested capital is -48.93% -
What Is Intellia Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -40.26% -
What Is NTLA Return On Equity?
ROE is a measure of profitability and is -48.93%
Intellia Therapeutics Earnings Date & Stock Price
-
What Is Intellia Therapeutics's Stock Price Today?
A single share of NTLA can be purchased today for 22.55 -
What Is Intellia Therapeutics’s Stock Symbol?
Intellia Therapeutics trades on the nasdaq under the ticker symbol: NTLA -
When Is Intellia Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Intellia Therapeutics is scheduled on November 8, 2024 -
When Is NTLA's next ex-dividend date?
Intellia Therapeutics's next ex-dividend date is September 18, 2024 -
How To Buy Intellia Therapeutics Stock?
You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Intellia Therapeutics Competitors
-
Who Are Intellia Therapeutics's Competitors?
Below is a list of companies who compete with Intellia Therapeutics or are related in some way:
Intellia Therapeutics Dividend Yield
-
What Is NTLA Dividend Yield?
Intellia Therapeutics’s dividend yield currently is 0% -
What Is Intellia Therapeutics’s Payout Ratio?
Intellia Therapeutics’s payout ratio is 0% -
When Did Intellia Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 18, 2024 -
What Is Intellia Therapeutics’s Dividend Per Share?
Intellia Therapeutics pays a dividend of $0.00 per share
Intellia Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -27.02% |
| Revenue: | -48.82% | -63.69% |
Analyst Recommendations
| Buy Recommendations: | 17 |
|---|---|
| Hold Recommendations: | 6 |
| Sell Recommendations: | 0 |
| Price Target: | 68.50 |
| Upside from Last Price: | 203.78% |